R

Runway Growth Finance Corp
NASDAQ:RWAY

Watchlist Manager
Runway Growth Finance Corp
NASDAQ:RWAY
Watchlist
Price: 6.81 USD -2.99% Market Closed
Market Cap: $246m

Runway Growth Finance Corp
Investor Relations

Runway Growth Finance Corp. is a specialty finance company. The company is headquartered in Chicago, Illinois and currently employs 0 full-time employees. The company went IPO on 2021-10-21. The firm partners with established venture capital sponsors and directly with entrepreneurs seeking funding to accelerate growth. Its investment objective is to maximize its total return to its stockholders primarily through current income on the Company's loan portfolio and secondarily through capital appreciation on its warrants and other equity positions, by providing its portfolio companies with financing solutions that are more flexible than traditional credit and less dilutive than equity. The firm is managed by its adviser, Runway Growth Capital LLC, a provider of growth financing for mid-to-late and growth stage companies.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Mar 12, 2026
AI Summary
Q4 2025

Earnings: Total investment income was $30 million and net investment income was $11.6 million in Q4 2025, down from $36.7 million and $15.7 million in Q3.

Dividends: Q4 NII per share was $0.32; base dividend was $0.33 per share and the Board declared a Q1 2026 regular distribution of $0.33 per share.

SWK Acquisition: The pending SWK Holdings acquisition is expected to close in early April (around April 6); management expects mid-single-digit run-rate NII accretion and reduced portfolio risk after closing.

Portfolio: Funded 7 investments totaling $42.9 million in Q4; portfolio fair value was $927.4 million (down 2% sequentially) with one nonaccrual loan (Domingo Healthcare) representing 0.25% of the portfolio at fair value.

Capital & Liquidity: Available liquidity was $395.2 million and borrowing capacity $377 million; launched $103.25 million unsecured notes due Feb 2031 at 7.25% and redeemed part/all of certain 2027 notes.

Leverage guidance: Pro forma leverage after SWK will be just under 1.2 and management targets running between 1.2 and 1.3 over time.

Headwinds: Q1 2026 will see some softness from the SWK timing delay and a $0.02 one-time charge related to redemption of near-term notes.

Key Financials
Total investment income (Q4 2025)
$30 million
Net investment income (Q4 2025)
$11.6 million
Net investment income per share (Q4 2025)
$0.32
Base dividend per share
$0.33
Spillover income (year-end)
$0.65 per share (approx.)
Weighted average portfolio risk rating
2.45
Total investment portfolio fair value
$927.4 million
Nonaccrual loans (count)
1 (Domingo Healthcare)
Domingo Healthcare loan cost basis
$4.8 million
Domingo Healthcare fair market value
$2.4 million (50% of cost)
Domingo Healthcare share of portfolio (FV)
0.25%
Net assets (12/31/2025)
$484.9 million
NAV per share (12/31/2025)
$13.42
Leverage ratio (12/31/2025)
0.9
Asset coverage
2.11x
Total available liquidity
$395.2 million
Borrowing capacity
$377 million
Unfunded commitments
$145.5 million
Unfunded debt commitments
$122.8 million
Unfunded equity commitments (Cadma JV)
$22.7 million
Unfunded debt commitments eligible to draw
$32.4 million
Quarterly funded investments (Q4 2025)
$42.9 million (7 investments)
Follow-on investments (Q4 2025)
$10.9 million to 4 companies
Specific new investments (Q4 2025)
$20 million mobility; $10 million consumer SPV; $20 million to Shield Therapeutics (funded $2 million at close)
Debt portfolio dollar-weighted average annualized yield (Q4 2025)
14.2%
SWK portfolio fair value (expected at close)
approximately $235 million (13 loans)
SWK portfolio yields
total portfolio ~14%; debt-only ~16%
New unsecured notes launched (post quarter)
$103.25 million due Feb 2031 at 7.25%
Expected pro forma leverage after SWK
just under 1.2
Average position size target post-SWK
$23.5 million (2.2% of portfolio)
Expected one-time Q1 2026 charge
$0.02 per share headwind
Earnings Call Recording
Other Earnings Calls

Management

Mr. David R. Spreng
Founder, Chairman of the Board, President, CIO & CEO
No Bio Available
Mr. Thomas B. Raterman
CFO, COO, Secretary & Treasurer
No Bio Available
Ms. Quinlan Abel
Assistant Vice President of Investor Relations
No Bio Available
Ms. Colleen Corwell
Chief Compliance Officer
No Bio Available
Mr. Ted Cavan
Managing Director of Technology
No Bio Available

Contacts

Address
ILLINOIS
Chicago
205 N Michigan Ave Ste 4200
Contacts
+13122816270.0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett